AnalysisNews

MDXH today

$0.15+$0.01 (+5.17%)close Nov 11, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bearish

1 hourBullish

15 minSymmetric Triangle

5 minExpanding

Daily trend turns up above $0.22

Key levels

Resistance$0.42

Resistance$0.22

Support$0.14

Latest news & SEC filings

AnalystBTIG downgrades MDxHealth to Neutral from Buy

AnalystMDxHealth Cut to Neutral at BTIG, Down From Buy

AnalystBTIG Downgrades MDxHealth to Neutral

All MDXH news →

About MDxHealth

MDxHealth is a molecular diagnostics company that develops and commercializes tests for prostate cancer and other urologic conditions. Its main offerings include Confirm mdx, a tissue-based test, and Exo mdx, a urine-based test, along with GPS mdx, Resolve mdx, and Monitor mdx. The company serves healthcare providers, patients, and payors, primarily in the United States and Europe.

Based on the company's 20-F filed Apr 3, 2026.

Nasdaq · Healthcare

MDxHealth SA (MDXH)

$0.15+0.01 (+5.17%)
WATCHLISTGrade: C+Risk: HIGH
1D5D1M1Y5YMaxSign up for all timeframes
0.240.350.450.560.15Oct 9Oct 19Oct 27Nov 4
High0.15
Low0.14
Open0.14
Volume1.16M
Avg Vol1.34M
VWAP0.15
30d High0.66
30d Low0.14
30d Chg-74.57%

What Is the Price Target for MDXH?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.15Upside: +0.0%Confidence: 20%Method: No Coverage

Is MDXH a Buy or Sell Right Now?

47
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 19.8% YoY with STRONG trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MDXH.

Start Free Trial →

Is MDXH Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

PEG

Fair Value

$0.91

57

Moat Score

NARROW

3/9

Piotroski Score

-3.3

Altman Z-Score

What Is Smart Money Doing with MDXH?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

MDXH Growth Story

Revenue YoY

19.8%

3yr Revenue CAGR

42.8%

EPS Growth YoY

42.24%

FCF Growth YoY

44.1%

Revenue Trend

STRONG

Dark Pool Trades for MDXH

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for MDXH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
20:56:32$0.151,100$$161SELL
20:52:08$0.1528,600$$4KMIDPOINT
20:52:08$0.1511,300$$2KMIDPOINT
20:51:35$0.153,600$$531SELL
20:51:35$0.155,561$$820SELL

5 dark pool trades shown · $$7K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for MDxHealth SA (MDXH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

MDXH — frequently asked questions

What is MDXH stock price today?

MDxHealth SA (MDXH) is at $0.15, up 5.17% (+$0.01) at the Nov 11, 2026 close.

Why is MDXH stock moving today?

Latest MDXH news — Oct 19, 2026: BTIG downgrades MDxHealth to Neutral from Buy · Oct 19, 2026: MDxHealth Cut to Neutral at BTIG, Down From Buy

What do analysts rate MDXH?

Analyst ratings for MDXH: 0 Buy, 4 Hold, 0 Sell — consensus Hold.

Did MDXH beat earnings?

MDXH last reported on Aug 13, 2026: EPS -$0.18 vs -$0.19 expected — a beat of 6.9%.

Does MDXH pay a dividend?

MDXH does not currently pay a dividend.

How much debt does MDXH have?

MDxHealth SA reported $95M of debt and $29M of cash (Dec 31, 2025).

What are MDXH support and resistance levels?

Support: $0.14. Resistance: $0.22, $0.42, $0.46.

What are insiders doing with MDXH?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on MDXH?

Oct 19, 2026: BTIG downgrades MDxHealth to Neutral from Buy · Oct 19, 2026: MDxHealth Cut to Neutral at BTIG, Down From Buy · Oct 19, 2026: BTIG Downgrades MDxHealth to Neutral